99 related articles for article (PubMed ID: 6207331)
21. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.
Hashimoto K; Tsujimura T; Moriyama Y; Yamatodani A; Kimura M; Tohya K; Morimoto M; Kitayama H; Kanakura Y; Kitamura Y
Am J Pathol; 1996 Jan; 148(1):189-200. PubMed ID: 8546206
[TBL] [Abstract][Full Text] [Related]
22. Rat myoblastic sarcoma cell lines. A model for the study of invasion, metastasis, and myogenic differentiation.
Babaï F; Royal A
Lab Invest; 1994 Jun; 70(6):907-15. PubMed ID: 8015294
[TBL] [Abstract][Full Text] [Related]
23. Emergence of hamster fibroblast tumors in nude mice--evidence for in vivo selection leading to loss of growth factor requirement.
Pérez-Rodriguez R; Chambard JC; Van Obberghen-Schilling E; Franchi A; Pouysségur J
J Cell Physiol; 1981 Dec; 109(3):387-96. PubMed ID: 7320057
[TBL] [Abstract][Full Text] [Related]
24. [Differentiation therapy for salivary gland tumors].
Sato M
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1028-36. PubMed ID: 7685583
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
26. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.
Horwitz M
Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953
[TBL] [Abstract][Full Text] [Related]
28. Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.
Manohar M; Orrison B; Peden K; Lewis AM
Biologicals; 2008 Jan; 36(1):65-72. PubMed ID: 17933552
[TBL] [Abstract][Full Text] [Related]
29. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
Crouch GD; Kalebic T; Tsokos M; Helman LJ
Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of proliferation, invasion and adhesion of liver cancer cells by 5-azacytidine and butyrate.
Wang XM; Li J; Evers BM
Anticancer Res; 1999; 19(4B):2901-6. PubMed ID: 10652571
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7.
Zenklusen JC; Oshimura M; Barrett JC; Conti CJ
Oncogene; 1994 Oct; 9(10):2817-25. PubMed ID: 8084587
[TBL] [Abstract][Full Text] [Related]
32. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenicity and other properties of cells from ten continuous human esophageal carcinoma cell lines in nude mice.
Robinson KM; Maistry L
J Natl Cancer Inst; 1983 Jan; 70(1):89-93. PubMed ID: 6571927
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation levels in porcine fetal fibroblasts induced by an inhibitor of methylation, 5-azacytidine.
Mohana Kumar B; Jin HF; Kim JG; Song HJ; Hong Y; Balasubramanian S; Choe SY; Rho GJ
Cell Tissue Res; 2006 Sep; 325(3):445-54. PubMed ID: 16683140
[TBL] [Abstract][Full Text] [Related]
36. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
Benedict WF; Wheatley WL; Jones PA
Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic variance among cells isolated from spontaneous mouse mammary tumors in primary suspension culture.
Soule HD; Maloney T; McGrath CM
Cancer Res; 1981 Mar; 41(3):1154-64. PubMed ID: 7459857
[TBL] [Abstract][Full Text] [Related]
39. Tumorigenic conversion resulting from inhibition of apoptosis in a nontumorigenic HeLa-derived hybrid cell line.
Oka K; Qi B; Yutsudo M
Cancer Res; 1999 Apr; 59(8):1816-9. PubMed ID: 10213483
[TBL] [Abstract][Full Text] [Related]
40. Loss of differentiation control in transformed 3T3 T proadipocytes.
Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
